Brain protective efficacy of nalmefene for patients with brain tumor undergone operation

Shu-Kun HU,Feng-Ping HUANG,Kang ZHENG

DOI: https://doi.org/10.16636/j.cnki.jinn.2011.04.013

2011-01-01

Abstract:Objective To evaluate the efficacy and safety of nalmefene in the postoperative treatment of patients with brain tumor.Methods 312 patients with brain tumors operated were randomly divided into treatment and control groups.Treatment group has 160 patients and control group has 152 patients.The control group received conventional therapy,and the treatment group was administered with nalmefene injection for 5 days beside the conventional therapy.The therapeutic effects were evaluated by the GCS 3,7,14 and 90 days after treatment.The neurological function was evaluated by the Barthel Index(BI) 3,7,14 and 90 days after treatment.The long-term prognosis was evaluated by the Karnofsky Index 90 days after treatment.Results The GCS score in the treatment group was significantly higher than that in the control group 3 and 90 days after treatment(P<0.05).After treatment,the BI indicated a higher recovery rate in the treatment group than controls(P<0.05) in day 14 and 90.the Karnofsky Index shows better clinical prognosis in the treatment group(P<0.05) 90 days after treatment.No adverse events were found.Conclusions Nalmefene is an effective and safe treatment for patients with brain tumor operated.